Skip to content
Search

Latest Stories

Steve Barclay to work with community pharmacists to 'tackle barriers' to offering more services

The Secretary of State for Health and Social Care Steve Barclay has expressed his interest to work with ‘community pharmacists in tackling barriers to offer more services’ from the sector.

Community pharmacists can support with many more things to ease pressure on general practice, Barclay told parliament while he was updating on ‘what the government is doing to help the NHS deal with immediate winter pressures on Monday (9 January).


He further updated that from the end of March community pharmacies will take referrals from ‘Urgent and Emergency Care’ settings.

He added: “Later this year we will also start offering oral contraceptive services, including how we better use digital services.”

The service was originally planned to commence on 11th January 2023 and was delayed to ‘early 2023’.

“The primary care recovery plan will set out a range of additional services pharmacists can deliver,” Barclay said.

Responding to his statement, the Pharmaceutical Services Negotiating Committee (PSNC) commented: “We were pleased to hear the Secretary of State talking so positively and hope he is convinced of the case for investment in community pharmacies so that they can do more to help the NHS and the public it serves at this very difficult time.”

It added: “PSNC has aways believed that with greater integration, capacity and sustainable funding, community pharmacy can be a key part of the solution for big NHS challenges such as GP access.”

“It was good to hear the Secretary of State recognising that along with all the wider value that pharmacies deliver.”

The committee has been discussing a fully funded Pharmacy First scheme with the Government for many months – “putting a business case forward for this in our CPCF negotiations last Spring. We remain ready to start negotiations on this as soon as they want to.”

“As we said in our recent letter to the Secretary of State, the Government is now at a fork in the road – it must decide whether it wants that sustainable, fully resourced community pharmacy sector which could continue to deliver huge value to patients while also doing more to ease wider NHS pressures; or does it want to continue to degrade our sector and the services that so many people rely on. We very much hope the Secretary of State agrees it must be the former, and that Government is ready to back this with appropriate funding.”

On Saturday (7 January), the Association of Independent Multiple Pharmacies (AIMp) board director and member and also the executive director of Day Lewis, Jay Patel highlighted the key issues and on ground challenges faced by the community pharmacy at the ‘pan- healthcare roundtable' discussions hosted by Prime Minister Rishi Sunak and the health secretary in Downing Street.

Dr Leyla Hannbeck, chief executive AIMp said: “We welcome the announcement by Secretary of State for health and social care Steve Barclays on 9 January eluding to government’s desire to progress a Pharmacy First scheme for England.”

“Pharmacy First scheme has historically presented a challenge for negotiators to land in recent years. It is clear barriers have existed to the notion of efficacious products being available readily through the pharmacy network - we hope that this is now fast tracked underpinned by a willingness to happen in the light of huge capacity challenges facing the NHS.”

The association hopes that Pharmacy First becomes the catalyst to future pathways delivered by community pharmacy in order to improve patients access to care - for example a vaccination first scheme as part of the prevention agenda, and integration to management of long term conditions.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less